Literature DB >> 8953187

High-performance liquid chromatographic determination of fluconazole in plasma.

M Cociglio1, S Brandissou, R Alric, F Bressolle.   

Abstract

A high-performance liquid chromatographic method with ultraviolet absorbance detection at 260 nm was developed for the analysis of fluconazole in plasma. The method involves sample clean-up by liquid-liquid extraction. The proposed technique is reproducible, selective, reliable and sensitive. Calibration standards were prepared in the range 1.25-20 mg/l. The limit of quantitation was 0.4 mg/l. The coefficients of variation were 5% between measurements of a single extract injected in duplicate, and 7% between two extractions of spiked samples at the same concentrations. The separation between fluconazole and endogenous substances was satisfactory. This method was designed in order to minimise the risk of interference from substances that could be co-administered to critically ill patients undergoing hemodiafiltration. With a run time below 5 min, the present method is rapid and easy to use for later clinical studies, as well as for routine monitoring.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953187     DOI: 10.1016/s0378-4347(96)00047-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  4 in total

1.  Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients.

Authors:  Silvia Regina Cavani Jorge Santos; Edvaldo Vieira Campos; Cristina Sanches; David Souza Gomez; Marcus Castro Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

2.  Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration.

Authors:  Kazuaki Yagasaki; Satoshi Gando; Naoyuki Matsuda; Takashi Kameue; Toshiteru Ishitani; Takeshi Hirano; Ken Iseki
Journal:  Intensive Care Med       Date:  2003-09-13       Impact factor: 17.440

3.  Differential genotype dependent inhibition of CYP2C9 in humans.

Authors:  Vikas Kumar; Richard C Brundage; William S Oetting; Ilo E Leppik; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2008-03-31       Impact factor: 3.922

4.  A sensitive method for analyzing fluconazole in extremely small volumes of neonatal serum.

Authors:  Jumpei Saito; Ayano Tanzawa; Yuka Kojo; Hidehiko Maruyama; Tetsuya Isayama; Kensuke Shoji; Yushi Ito; Akimasa Yamatani
Journal:  J Pharm Health Care Sci       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.